Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

TEM vs. DOCS: Which Medical-Tech Stock Looks Promising Amid AI Boom?
TEM vs. DOCS: Which Medical-Tech Stock Looks Promising Amid AI Boom?

Advancements in artificial intelligence (AI) within the medical technology industry are playing a significant role in improving patient lives by enabling innovative care delivery, reducing

Parker-Hannifin (PH) Q2 Earnings and Revenues Top Estimates
Parker-Hannifin (PH) Q2 Earnings and Revenues Top Estimates

Parker-Hannifin (PH) came out with quarterly earnings of $7.65 per share, beating the Zacks Consensus Estimate of $7.15 per share. This compares to earnings of $6.53 per share a year ago. These

ManpowerGroup (MAN) Tops Q4 Earnings and Revenue Estimates
ManpowerGroup (MAN) Tops Q4 Earnings and Revenue Estimates

ManpowerGroup (MAN) came out with quarterly earnings of $0.92 per share, beating the Zacks Consensus Estimate of $0.83 per share. This compares to earnings of $1.02 per share a year ago. These

West Bancorp (WTBA) Q4 Earnings and Revenues Surpass Estimates
West Bancorp (WTBA) Q4 Earnings and Revenues Surpass Estimates

West Bancorp (WTBA) came out with quarterly earnings of $0.61 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.42 per share a year ago. These

Coastal Financial Corporation (CCB) Q4 Earnings and Revenues Lag Estimates
Coastal Financial Corporation (CCB) Q4 Earnings and Revenues Lag Estimates

Coastal Financial Corporation (CCB) came out with quarterly earnings of $0.82 per share, missing the Zacks Consensus Estimate of $1.16 per share. This compares to earnings of $0.94 per share a year

First Northwest Bancorp (FNWB) Q4 Earnings Miss Estimates
First Northwest Bancorp (FNWB) Q4 Earnings Miss Estimates

First Northwest Bancorp (FNWB) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to a loss of $0.32 per share a year ago

Mondelez's Q4 Earnings on Deck: What to Expect From MDLZ Stock?
Mondelez's Q4 Earnings on Deck: What to Expect From MDLZ Stock?

Mondelez International, Inc. MDLZ is likely to witness top and bottom-line growth when it reports fourth-quarter 2025 earnings on Feb. 3. The Zacks Consensus Estimate for revenues is pegged at $10.3

What the LNG Wave Means for Gas Market Exposure in 2026
What the LNG Wave Means for Gas Market Exposure in 2026

Global natural gas demand is expected to pick up again in 2026 as a new wave of liquefied natural gas (“LNG”) supply changes how the market functions. Large capacity additions, mainly from North

Can Agnico Eagle's Solid Free Cash Flow Drive Its Next Growth Phase?
Can Agnico Eagle's Solid Free Cash Flow Drive Its Next Growth Phase?

Agnico Eagle Mines Limited AEM logged robust third-quarter free cash flow of roughly $1.2 billion, nearly doubling the prior-year figure of $620 million. The surge was backed by the strength in gold

Buy Corning as a Potential AI Beneficiary in 2026 Amid Robust Outlook
Buy Corning as a Potential AI Beneficiary in 2026 Amid Robust Outlook

Corning Inc. GLW – a giant communication components manufacturer – reported strong fourth-quarter 2025 earnings results. Adjusted earnings per share (EPS) of $0.72 surpassed the Zacks Consensus

Fabrinet Set to Report Q2 Earnings: What's in the Cards for the Stock?
Fabrinet Set to Report Q2 Earnings: What's in the Cards for the Stock?

Fabrinet FN is slated to release second-quarter fiscal 2026 results on Feb. 2.For the fiscal second quarter, revenues are expected in the range of $1.05-$1.10 billion. Non-GAAP earnings per share

Scotts Miracle-Gro's Q1 Earnings and Revenues Beat Estimates
Scotts Miracle-Gro's Q1 Earnings and Revenues Beat Estimates

The Scotts Miracle-Gro Company SMG reported a first-quarter fiscal 2026 (ended Dec. 27, 2025) loss of $125 million or $2.16 per share compared with a loss of $69.5 million or $1.21 per share in the

Is the Options Market Predicting a Spike in AMC Networks Stock?
Is the Options Market Predicting a Spike in AMC Networks Stock?

Investors in AMC Networks Inc. AMCX need to pay close attention to the stock based on moves in the options market lately. That is because the Jun 18, 2026 $2.5 Put had some of the highest implied

Lockheed Martin (LMT) Q4 Earnings Lag Estimates
Lockheed Martin (LMT) Q4 Earnings Lag Estimates

Lockheed Martin (LMT) came out with quarterly earnings of $5.8 per share, missing the Zacks Consensus Estimate of $6.24 per share. This compares to earnings of $7.67 per share a year ago. These

ConnectOne Bancorp (CNOB) Q4 Earnings Surpass Estimates
ConnectOne Bancorp (CNOB) Q4 Earnings Surpass Estimates

ConnectOne Bancorp (CNOB) came out with quarterly earnings of $0.83 per share, beating the Zacks Consensus Estimate of $0.74 per share. This compares to earnings of $0.52 per share a year ago. These

Valley National (VLY) Q4 Earnings and Revenues Beat Estimates
Valley National (VLY) Q4 Earnings and Revenues Beat Estimates

Valley National (VLY) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.13 per share a year ago. These

Company News for Jan 29, 2026
Company News for Jan 29, 2026
  • Starbucks Corporation (SBUX) shares fell 0.6% after reporting first-quarter fiscal 2026 earnings of $0.56 per share, missing the Zacks Consensus Estimate of $0.58 per share. 
  • MSCI Inc. (MSCI)
Are Options Traders Betting on a Big Move in Alkermes Stock?
Are Options Traders Betting on a Big Move in Alkermes Stock?

Investors in Alkermes plc ALKS need to pay close attention to the stock based on moves in the options market lately. That is because the Feb 20, 2026 $37 Put had some of the highest implied

Buy These 5 Low-Leverage Stocks as S&P 500 Touches Record Mark
Buy These 5 Low-Leverage Stocks as S&P 500 Touches Record Mark

Wall Street reached a historic milestone yesterday as the S&P 500 touched the 7,000 mark for the first time, fueled by the Federal Reserve’s decision to hold interest rates steady. Although the

FVRR vs. ETSY: Which AI-Powered Creator Marketplace Stock Has an Edge?
FVRR vs. ETSY: Which AI-Powered Creator Marketplace Stock Has an Edge?

Fiverr International FVRR and Etsy ETSY operate creator-led digital marketplaces connecting independent entrepreneurs with global demand. Fiverr enables the delivery of digital services such as

AXIS Capital Reports Q4 Earnings Growth Despite Higher Expenses
AXIS Capital Reports Q4 Earnings Growth Despite Higher Expenses

AXIS Capital Holdings Limited AXS reported fourth-quarter 2025 operating income of $3.25 per share, which outpaced the Zacks Consensus Estimate by 9.4% and rose 9.4% year over year.

The strong

Can Specialty and International Momentum Support Cencora's Q1 Results?
Can Specialty and International Momentum Support Cencora's Q1 Results?

Cencora COR is slated to report first-quarter fiscal 2026 results on Feb. 4, before market open.

In the last reported quarter, the company delivered an earnings surprise of 1.32%. COR’s earnings

GEV vs. PEG: Which Grid-Focused Energy Stock Is the Better Buy?
GEV vs. PEG: Which Grid-Focused Energy Stock Is the Better Buy?

The demand for clean electricity is accelerating worldwide, supported by a combination of long-term structural trends and rapid technological advances. Companies like GE Vernova GEV and Public

Implied Volatility Surging for Comstock Resources Stock Options
Implied Volatility Surging for Comstock Resources Stock Options

Investors in Comstock Resources, Inc. CRK need to pay close attention to the stock based on moves in the options market lately. That is because the Feb 20, 2026 $130.00 Call had some of the highest

Here's Why You Should Retain Glaukos Stock in Your Portfolio Now
Here's Why You Should Retain Glaukos Stock in Your Portfolio Now

Glaukos Corporation GKOS is well-poised for growth on the back of expansion of interventional glaucoma, clinical and commercial synergies between iDose TR and iStent infinite, and long-term